amiodarone and Acute Myelogenous Leukemia

amiodarone has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barve, A; Beverly, LJ; Ketchem, CJ; Kucera, C	1

Other Studies

1 other study(ies) available for amiodarone and Acute Myelogenous Leukemia

Article	Year
The Antiarrhythmic Drug, Amiodarone, Decreases AKT Activity and Sensitizes Human Acute Myeloid Leukemia Cells to Apoptosis by ABT-263. The American journal of the medical sciences, 2018, Volume: 355, Issue:5 Topics: Amiodarone; Aniline Compounds; Anti-Arrhythmia Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Acute; Proto-Oncogene Proteins c-akt; Sulfonamides; U937 Cells	2018

Article

Year

The Antiarrhythmic Drug, Amiodarone, Decreases AKT Activity and Sensitizes Human Acute Myeloid Leukemia Cells to Apoptosis by ABT-263.

The American journal of the medical sciences, 2018, Volume: 355, Issue:5

Topics: Amiodarone; Aniline Compounds; Anti-Arrhythmia Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Acute; Proto-Oncogene Proteins c-akt; Sulfonamides; U937 Cells

2018